1. Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial. Issue 9 (5th June 2018) Authors: Shimada, Akira; Hanafusa, Toshiaki; Yasui, Atsutaka; Lee, Ganghyuck; Taneda, Yusuke; Sarashina, Akiko; Shiki, Kosuke; George, Jyothis; Soleymanlou, Nima; Marquard, Jan Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 9(2018) Page Start: 2190 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Incidence and prevalence of diabetic ketoacidosis (DKA) among adults with type 1 diabetes mellitus (T1D): a systematic literature review. Issue 7 (1st August 2017) Authors: Farsani, Soulmaz Fazeli; Brodovicz, Kimberly; Soleymanlou, Nima; Marquard, Jan; Wissinger, Erika; Maiese, Brett A Journal: BMJ open Issue: Volume 7:Issue 7(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Kidney Effects of Empagliflozin in People with Type 1 Diabetes. Issue 11 (November 2021) Authors: Cherney, David Z.I.; Bjornstad, Petter; Perkins, Bruce A.; Rosenstock, Julio; Neubacher, Dietmar; Marquard, Jan; Soleymanlou, Nima Journal: Clinical journal of the American Society of Nephrology Issue: Volume 16:Issue 11(2021) Page Start: 1715 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Low‐dose empagliflozin as adjunct‐to‐insulin therapy in type 1 diabetes: A valid modelling and simulation analysis to confirm efficacy. Issue 3 (21st January 2020) Authors: Perkins, Bruce A.; Soleymanlou, Nima; Rosenstock, Julio; Skyler, Jay S.; Laffel, Lori M.; Liesenfeld, Karl‐Heinz; Neubacher, Dietmar; Riggs, Matthew M.; Johnston, Curtis K.; Eudy‐Byrne, Rena J.; Elmokadem, Ahmed; George, Jyothis T.; Marquard, Jan; Nock, Valerie Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 3(2020) Page Start: 427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patient preferences for newer oral therapies in type 2 diabetes. (15th January 2023) Authors: Savarese, Gianluigi; Sharma, Abhinav; Pang, Christianne; Wood, Richard; Soleymanlou, Nima Journal: International journal of cardiology Issue: Volume 371(2023) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Population Pharmacokinetic– Pharmacodynamic Analysis to Characterize the Effect of Empagliflozin on Renal Glucose Threshold in Patients With Type 1 Diabetes Mellitus. (18th December 2017) Authors: Mondick, John; Riggs, Matthew; Kaspers, Stefan; Soleymanlou, Nima; Marquard, Jan; Nock, Valerie Journal: Journal of clinical pharmacology Issue: Volume 58:Number 5(2018) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Renal and Vascular Effects of Combined SGLT2 and Angiotensin-Converting Enzyme Inhibition. Issue 6 (11th July 2022) Authors: Lytvyn, Yuliya; Kimura, Karen; Peter, Nuala; Lai, Vesta; Tse, Josephine; Cham, Leslie; Perkins, Bruce A.; Soleymanlou, Nima; Cherney, David Z.I. Journal: Circulation Issue: Volume 146:Issue 6(2022) Page Start: 450 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗